Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$144.34 USD
+1.91 (1.34%)
Updated May 17, 2024 04:00 PM ET
After-Market: $144.33 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DGX 144.34 +1.91(1.34%)
Will DGX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for DGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DGX
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
DGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down
Quest Diagnostics (DGX) Beats Q1 Earnings and Revenue Estimates
Other News for DGX
DGX July 19th Options Begin Trading
Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors
Quest Diagnostics Inc. stock outperforms competitors on strong trading day
Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics declares $0.75 dividend